Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population

Insulin Degludec (IDeg) is a new ultra-long-acting basal insulin that has not been yet evaluated in Indian pediatric population. We aim to evaluate the efficacy and safety of IDeg as basal-bolus therapy in Ind...

Source: International Journal of Pediatric Endocrinology - July 27, 2018 Category: Endocrinology Authors: Inderpal Singh Kochar and Aashish Sethi Tags: Research Source Type: research